Maiwald
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Sponsored
Sponsored
-
Sponsored by Maiwald Intellectual PropertyClaus Schindele of Maiwald considers the legal complications regarding patent protection in the offshore wind sector, with a particular eye on Germany and the UK -
Sponsored by Maiwald Intellectual PropertyKerstin Wolff of Maiwald reports on a proposal that supports the use of some plants generated by new genomic techniques but opposes patents for all plants obtained by such means
-
Sponsored by Maiwald Intellectual PropertyEva Ehlich and Anja Fux of Maiwald summarise an EPO board ruling relating to substances and compositions in the context of medical use claims and how it could affect applicants’ portfolio strategies
-
Sponsored by Maiwald Intellectual PropertyWhile some observers are of the view that an Enlarged Board of Appeal ruling failed to provide sufficient clarity, Eva Ehlich and Anja Fux of Maiwald say the picture concerning post-published evidence is becoming clearer
-
Sponsored by Maiwald Intellectual PropertySusanna Heurung of Maiwald welcomes a decision by the Board of Appeal regarding the extension of a grace period for use where the applicant’s bad faith was obvious
-
Sponsored by Maiwald Intellectual PropertyIn concluding a two-part series on springboard injunctions, Marco Stief of Maiwald takes a deeper dive to explain their requirements, review case law, and examine their relevance in the pharmaceutical and life sciences sectors
